Discover and read the best of Twitter Threads about #BariatricSurgery

Most recents (4)

@BassiMehak @MarcelYibirin @MondayNightIBD @kzhuangmd @agoldowskymd @IBD_FloMD @IBD_Afzali @babudayyeh @BolandBrigid @amjohnsonMD @PopovVioleta @RobertoSimonsMD @LauraChiuMD @PDulaiMD @HealthyLivingGI @oridamas @kehutchins77 @ven_satyam @MichelleKimMD @Chris_Velez_MD @traceyg_md @khalili_MD @ingrid_hickman @EdwardLoftus2 @ReemSharaiha @gutdoc18 @ThereziaR @CherylharrisRD @DBadurdeen @KellyHathornMD @GIdietitian 9/ Wt loss #Medications.
GLP-1:
✔️ ➕➕ for wt loss.
✔️ Safe in DM2 in IBD; may improve IBD activity
💥SE- nausea, 🤮, 💩🚽. Monitor closely
💥Orlistat- 🚫in IBD pts, esp with active small CD +/- chr malabsp syndrome
💥Phentermine-topiramate, Bupropion-naltrexone-⏬ efficacy Image
Read 5 tweets
The word ‘#obese’ is now considered unacceptable by the world’s academic community and should be changed by the @WHO to #obesity - because: a person has a disease called obesity and that person is NOT the disease itself. @pattynece @Eggface @PaulDavidsonPhD @ConscienHealth
Unfortunately the word ‘obese’ is still used as a medical term but many journals are NOW dropping it and editing content to the NEW correct terminology when referring to people, which is “person with obesity” @Nature @NEJM
Read 16 tweets
About 5 years ago I had 150 new people following me every day. My tweets were seen by many then one day it all stopped…. A website in Europe detected that I was #shadowbanned by @twitter 1/
Clearly my tweets and retweets were not getting the same impact - I had gained notoriety from my social media presence and I had no answers. I had no recourse. No one at #twitter would respond to my texts, emails, or calls. So… I just worked harder… 2/
I worked on influencing others on and off social media to advocate for fair treatment of those with #obesity and access to care for treatment- others became involved in social medi and #twitter 3/
Read 13 tweets
GLP-1-based therapies are slowly approaching #bariatricsurgery level #weightloss and more exciting science to come. There is the impressive SURMOUNT-1 trial for tirzepatide #obesity nejm.org/doi/full/10.10…
Among the compelling findings, 63% of subjects achieved > 20% #weightloss with 15 mg once weekly Tirzepatide over 72 weeks #obesity nejm.org/doi/full/10.10…
The results obtained with semaglutide and now tirzepatide provide compelling examples of how investments in science over time enable new more effective therapies for metabolic disorders #T2D #Obesity perhaps #NASH. These results also raise the bar for new mechanisms in the space
Read 4 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!